ENXTPA:IPNPharmaceuticalsAre Investors Undervaluing Ipsen S.A. (EPA:IPN) By 31%?September 28, 2023Key Insights The projected fair value for Ipsen is €178 based on 2 Stage Free Cash Flow to Equity Current share price...
ENXTPA:EAPIPharmaceuticalsEuroapi S.A.'s (EPA:EAPI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?September 27, 2023Euroapi's (EPA:EAPI) stock is up by a considerable 16% over the past three months. We wonder if and what role the...
ENXTPA:VIRPPharmaceuticalsIs There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?September 26, 2023Key Insights Virbac's estimated fair value is €411 based on 2 Stage Free Cash Flow to Equity Current share price of...
ENXTPA:VETOPharmaceuticalsIs Vetoquinol SA (EPA:VETO) Trading At A 45% Discount?September 12, 2023Key Insights Using the 2 Stage Free Cash Flow to Equity, Vetoquinol fair value estimate is €148 Vetoquinol's €81.10...
ENXTPA:IPNPharmaceuticalsThese 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably WellSeptember 07, 2023Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
ENXTPA:VIRPPharmaceuticalsHere's Why We Think Virbac (EPA:VIRP) Is Well Worth WatchingSeptember 05, 2023For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
ENXTPA:SANPharmaceuticalsIs Sanofi's (EPA:SAN) Recent Performance Tethered To Its Attractive Financial Prospects?September 04, 2023Sanofi's (EPA:SAN) stock is up by 5.0% over the past month. Given that the market rewards strong financials in the...
ENXTPA:EAPIPharmaceuticalsEuroapi S.A.'s (EPA:EAPI) market cap surged €56m last week, public companies who have a lot riding on the company were rewardedAugust 31, 2023Key Insights Significant control over Euroapi by public companies implies that the general public has more power to...
ENXTPA:BOIPharmaceuticalsBoiron SA (EPA:BOI) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?August 25, 2023Boiron's (EPA:BOI) stock is up by a considerable 38% over the past three months. However, we decided to pay attention...
ENXTPA:IPNPharmaceuticalsIpsen S.A. (EPA:IPN) most popular amongst private companies who own 31%, insiders hold 27%August 17, 2023Key Insights The considerable ownership by private companies in Ipsen indicates that they collectively have a greater...
ENXTPA:VIRPPharmaceuticalsInvesting in Virbac (EPA:VIRP) five years ago would have delivered you a 119% gainAugust 15, 2023The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...
ENXTPA:SANPharmaceuticalsIs There An Opportunity With Sanofi's (EPA:SAN) 47% Undervaluation?August 08, 2023Key Insights Using the 2 Stage Free Cash Flow to Equity, Sanofi fair value estimate is €177 Current share price of...
ENXTPA:MEDCLPharmaceuticalsIndividual investors who hold 53% of MedinCell S.A. (EPA:MEDCL) gained 13%, institutions profited as wellAugust 05, 2023Key Insights MedinCell's significant individual investors ownership suggests that the key decisions are influenced by...
ENXTPA:EAPIPharmaceuticalsAnalysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly ResultsAugust 04, 2023It's been a good week for Euroapi S.A. ( EPA:EAPI ) shareholders, because the company has just released its latest...
ENXTPA:EAPIPharmaceuticalsIs Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?August 02, 2023Key Insights Using the 2 Stage Free Cash Flow to Equity, Euroapi fair value estimate is €24.50 Euroapi is estimated to...
ENXTPA:IPNPharmaceuticalsIs Ipsen S.A.'s (EPA:IPN) Stock's Recent Performance A Reflection Of Its Financial Health?July 30, 2023Most readers would already know that Ipsen's (EPA:IPN) stock increased by 4.6% over the past three months. Since the...
ENXTPA:VETOPharmaceuticalsVetoquinol's (EPA:VETO) 12% CAGR outpaced the company's earnings growth over the same five-year periodJuly 30, 2023When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...
ENXTPA:VIRPPharmaceuticalsInsiders the biggest winners as Virbac SA's (EPA:VIRP) market cap rises to €2.4bJuly 27, 2023Key Insights Virbac's significant insider ownership suggests inherent interests in company's expansion A total of 2...
ENXTPA:SANPharmaceuticalsSanofi (EPA:SAN) jumps 5.5% this week, though earnings growth is still tracking behind five-year shareholder returnsJuly 21, 2023If you want to compound wealth in the stock market, you can do so by buying an index fund. But the truth is, you can...
ENXTPA:IPNPharmaceuticalsThose who invested in Ipsen (EPA:IPN) three years ago are up 42%July 12, 2023Low-cost index funds make it easy to achieve average market returns. But if you invest in individual stocks, some are...
ENXTPA:VIRPPharmaceuticalsIs Weakness In Virbac SA (EPA:VIRP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?July 08, 2023With its stock down 16% over the past month, it is easy to disregard Virbac (EPA:VIRP). However, a closer look at its...
ENXTPA:BOIPharmaceuticalsBoiron's (EPA:BOI) earnings trajectory could turn positive as the stock soars 30% this past weekJuly 06, 2023This month, we saw the Boiron SA ( EPA:BOI ) up an impressive 33%. But over the last half decade, the stock has not...
ENXTPA:VETOPharmaceuticalsIs Vetoquinol SA's (EPA:VETO) Latest Stock Performance Being Led By Its Strong Fundamentals?July 03, 2023Vetoquinol's (EPA:VETO) stock up by 7.3% over the past three months. Given that the market rewards strong financials in...
ENXTPA:SANPharmaceuticalsWith 57% ownership of the shares, Sanofi (EPA:SAN) is heavily dominated by institutional ownersJune 30, 2023Key Insights Given the large stake in the stock by institutions, Sanofi's stock price might be vulnerable to their...